Structure Therapeutics (GPCR) executive Lin gave up 12,846 shares at $6.84 to cover taxes or an exercise price
Insider transactions reported
Xichen Lin (Chief Scientific Officer at Structure Therapeutics Inc., GPCR) reported that they gave up 12,846 shares at $6.84 to cover taxes or an exercise price on Jul 1, 2025. After these transactions the filing shows 204,327 shares held directly.
- Reporting person
- Lin Xichen
- Role
- CHIEF SCIENTIFIC OFFICER
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jul 1, 2025 | Shares withheld for taxes or exercise price (F) | Ordinary Shares1, 2 | -12,846 | $6.84 | $87.8K | 204,327 direct |
Holdings before and after
- Ordinary Shares: 217,173 to 204,327 direct
Footnotes from the filing
- 1. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ( ADSs ). Each ADS represents three Ordinary Shares of the Issuer.
- 2. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Lin report in this GPCR Form 4?
Xichen Lin (Chief Scientific Officer at Structure Therapeutics Inc., GPCR) reported that they gave up 12,846 shares at $6.84 to cover taxes or an exercise price on Jul 1, 2025. After these transactions the filing shows 204,327 shares held directly.
How many GPCR shares does Lin hold after this filing?
The filing shows 204,327 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for GPCR
Earlier insider filings at GPCR
- Aug 20, 2025CHIEF TECHNOLOGY OFFICER Ma Yingli covered exercise/tax liability with 4,470 units of Ordinary Shares, decreasing direct ownership by 4% to 118,704 units (SEC Form 4)
- Aug 1, 2025SEC Form 4 filed by See Remark 1 Fmr Llc
- Jul 3, 2025CHIEF TECHNOLOGY OFFICER Ma Yingli covered exercise/tax liability with 1,824 units of Ordinary Shares and was granted 24,459 units of Ordinary Shares, increasing direct ownership by 23% to 123,174 units (SEC Form 4)
- Jul 3, 2025CHIEF MEDICAL OFFICER Coll Crespo Blas was granted 7,992 units of Ordinary Shares and covered exercise/tax liability with 2,667 units of Ordinary Shares, increasing direct ownership by 2% to 224,913 units (SEC Form 4)
- Jul 3, 2025CHIEF SCIENTIFIC OFFICER Lin Xichen covered exercise/tax liability with 6,441 units of Ordinary Shares and was granted 57,078 units of Ordinary Shares, increasing direct ownership by 30% to 217,173 units (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2023
Follow GPCR and get a push notification the moment its next story breaks.